A SMAD1/5-YAP signalling module drives radial glia self-amplification and growth of the developing cerebral cortex.
Sonia NajasIsabel PijuanAnna Esteve-CodinaSusana UsietoJuan D MartinezAn ZwijsenMaria L ArbonésElisa MartíGwenvael Le DréauPublished in: Development (Cambridge, England) (2020)
The growth and evolutionary expansion of the cerebral cortex are defined by the spatial-temporal production of neurons, which itself depends on the decision of radial glial cells (RGCs) to self-amplify or to switch to neurogenic divisions. The mechanisms regulating these RGC fate decisions are still incompletely understood. Here, we describe a novel and evolutionarily conserved role of the canonical BMP transcription factors SMAD1/5 in controlling neurogenesis and growth during corticogenesis. Reducing the expression of both SMAD1 and SMAD5 in neural progenitors at early mouse cortical development caused microcephaly and an increased production of early-born cortical neurons at the expense of late-born ones, which correlated with the premature differentiation and depletion of the pool of cortical progenitors. Gain- and loss-of-function experiments performed during early cortical neurogenesis in the chick revealed that SMAD1/5 activity supports self-amplifying RGC divisions and restrains the neurogenic ones. Furthermore, we demonstrate that SMAD1/5 stimulate RGC self-amplification through the positive post-transcriptional regulation of the Hippo signalling effector YAP. We anticipate this SMAD1/5-YAP signalling module to be fundamental in controlling growth and evolution of the amniote cerebral cortex.
Keyphrases
- transforming growth factor
- epithelial mesenchymal transition
- transcription factor
- spinal cord injury
- functional connectivity
- spinal cord
- cerebral ischemia
- induced apoptosis
- gene expression
- immune response
- mesenchymal stem cells
- gestational age
- autism spectrum disorder
- nucleic acid
- neuropathic pain
- low birth weight
- dna methylation
- bone marrow
- cell proliferation
- cell death
- preterm infants
- preterm birth
- binding protein
- type iii